NCT05812794

Brief Summary

The purpose of this study is to evaluate the tolerability of tDCS in childhood stroke survivors and to assess for improvement in arm function in patients receiving tDCS and occupational therapy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 14, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

June 30, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 11, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2024

Completed
7 months until next milestone

Results Posted

Study results publicly available

September 26, 2024

Completed
Last Updated

September 26, 2024

Status Verified

August 1, 2024

Enrollment Period

5 months

First QC Date

March 30, 2023

Results QC Date

August 29, 2024

Last Update Submit

August 29, 2024

Conditions

Keywords

neuromodulationtranscranial direct current stimulationstrokerehabilitationchildhood stroke

Outcome Measures

Primary Outcomes (2)

  • Number of Participants Who Complete the Study

    1-week post therapy

  • Arm Function as Assessed by the Fugl-Meyer Score of Upper Extremity Function

    Scoring is based on direct observation of performance. Scale items are scored on the basis of ability to complete the item using a 3-point ordinal scale where 0=cannot perform; 1=performs partially; and 2=performs fully. Total score ranges from 0 to 66, with a higher score indicating greater arm function.

    1 week post therapy

Secondary Outcomes (5)

  • Tolerability as Assessed by the Number of Patients That Endorse Any Side Effects as Documented on the Stimulation Monitoring Sheet

    immediately post stimulation Day 1, immediately post stimulation Day 2, immediately post stimulation Day 3, immediately post stimulation Day 4, immediately post stimulation Day 5

  • Tolerability as Assessed by the Number of Patients With Hypotension or Hypertension on Blood Pressure Monitoring

    From baseline to 1 week post-therapy session

  • Tolerability as Assessed by the Number of Patients With a Decrease in Score of 5 or Greater on the Peg-Board Test

    Baseline, immediately post stimulation Day 5

  • Arm Function as Assessed by the Fugl-Meyer Score of Upper Extremity Function

    3 month post therapy

  • Change in Quality of Unilateral Upper Limb Movement as Assessed by the Melbourne Assessment of the Upper Extremity (MUUL)

    Baseline,1 week post therapy , 3 months post therapy

Other Outcomes (2)

  • Global Function as Assessed by Score on the Pediatric Stroke Outcome Measure (PSOM) Rating Scale

    1 week post therapy

  • Global Function as Assessed by Score on the Pediatric Stroke Outcome Measure (PSOM) Rating Scale

    3 months post therapy

Study Arms (1)

Transcranial Direct Current Stimulation (tDCS)

EXPERIMENTAL
Device: Transcranial Direct Current Stimulation (tDCS)

Interventions

Participants will come for 5 sequential days of 2 hour long occupational therapy sessions augmented by tDCS for the first 20 minutes of the session. At arrival, the "stimulation safety sheet" will be completed by the occupational therapist.The saline soaked electrodes will be placed on the study subjects head and connected to the Soterix 1x1 Limited Total Energy (LTE) enabled tDCS device. Current output through the device will be sham stimulation on day 1 , followed by steady increases to a maximum of 1milliampere (mA) in patients aged 5-12 years old, and 1.5 mA in patients aged 13-19 years old, per the study design flow sheet at the end of this protocol. Blood pressure, pulse rate, and peg-board scores will be recorded as indicated on the stimulation safety sheet during each session.A repeat assessment will be done by the occupational therapist one week post therapy completion.There will be a repeat assessment visit 3 months post intervention.

Transcranial Direct Current Stimulation (tDCS)

Eligibility Criteria

Age5 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Childhood stroke survivor - either arterial ischemic stroke or intracerebral hemorrhage.
  • Stroke must be childhood onset, defined as occurring day 29 of life to 18 years of age (per the American Heart Association's definition of childhood stroke)
  • months or greater from stroke onset
  • Arm impairment, defined as pediatric stroke outcome measure of 1 or greater of affected arm.
  • Affected arm Fugl-Meyer score of 60 or lower.
  • Able to participate in occupational therapy sessions.

You may not qualify if:

  • Uncontrolled epilepsy, defined as seizure within the past 6 months.
  • Craniectomy without replacement of bone flap. Patients who underwent craniectomy will need the bone flap reattached prior to participation.
  • Presence of cranial metal implants or implant device that could be affected by tDCS: cochlear implant, implanted brain stimulator, or programmable ventriculoperitoneal shunt.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

Related Publications (1)

  • Fraser S, Clearman A, Abrahams M, Gillick B, Lal T, Savitz S, Yozbatiran N. TOPSS: TOlerability of transcranial direct current stimulation in Pediatric Stroke Survivors. Front Hum Neurosci. 2025 Aug 5;19:1629499. doi: 10.3389/fnhum.2025.1629499. eCollection 2025.

MeSH Terms

Conditions

Stroke

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Results Point of Contact

Title
Stuart Mason Fraser, MD
Organization
The University of Texas Health Science Center at Houston

Study Officials

  • Stuart M Fraser, MD

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 30, 2023

First Posted

April 14, 2023

Study Start

June 30, 2023

Primary Completion

December 11, 2023

Study Completion

March 15, 2024

Last Updated

September 26, 2024

Results First Posted

September 26, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations